ABCG2 and cancer: In this study, we showed that afatinib exerted inhibitory effects on ABCG2 function via dual mechanisms, competitive block of substrate transport and downregulation of ABCG2 expression, thereby reversing ABCG2-mediated drug resistance in various cancer cells with ABCG2 overexpression in vitro and in vivo.